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RESEARCH ARTICLE
Interleukin-1 signaling induced 
by Streptococcus suis serotype 2 
is strain-dependent and contributes to bacterial 
clearance and inflammation during systemic 
disease in a mouse model of infection
Agustina Lavagna1, Jean‑Philippe Auger1, Audrey Dumesnil1, David Roy1, Stephen E. Girardin2, Nicolas Gisch3, 
Mariela Segura1 and Marcelo Gottschalk1* 
Abstract 
Streptococcus suis serotype 2 is an important porcine pathogen and zoonotic agent causing sudden death, septic 
shock and meningitis, with exacerbated inflammation being a hallmark of the infection. A rapid, effective and bal‑
anced innate immune response against S. suis is critical to control bacterial growth without causing excessive inflam‑
mation. Even though interleukin (IL)‑1 is one of the most potent and earliest pro‑inflammatory mediators produced, 
its role in the S. suis pathogenesis has not been studied. We demonstrated that a classical virulent European sequence 
type (ST) 1 strain and the highly virulent ST7 strain induce important levels of IL‑1 in systemic organs. Moreover, bone 
marrow‑derived dendritic cells and macrophages contribute to its production, with the ST7 strain inducing higher 
levels. To better understand the underlying mechanisms involved, different cellular pathways were studied. Indepen‑
dently of the strain, IL‑1β production required MyD88 and involved recognition via TLR2 and possibly TLR7 and TLR9. 
This suggests that the recognized bacterial components are similar and conserved between strains. However, very 
high levels of the pore‑forming toxin suilysin, produced only by the ST7 strain, are required for efficient maturation 
of pro‑IL‑1β via activation of different inflammasomes resulting from pore formation and ion efflux. Using IL‑1R−/− 
mice, we demonstrated that IL‑1 signaling plays a beneficial role during S. suis systemic infection by modulating the 
inflammation required to control and clear bacterial burden, thus promoting host survival. Beyond a certain threshold, 
however, S. suis‑induced inflammation cannot be counterbalanced by this signaling, making it difficult to discriminate 
its role.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Streptococcus suis causes sudden death and meningitis 
in pigs and is responsible for important economic losses 
to the swine industry. Furthermore, it is also a zoonotic 
agent responsible for meningitis and septic shock in 
humans [1, 2]. Of the 35 described serotypes, serotype 
2 is the most virulent and most frequently isolated from 
both pigs and humans worldwide [3]. Using multilocus 
sequence typing, four predominant sequence types (STs) 
have been identified within serotype 2 strains: the viru-
lent ST1 in Eurasia, the highly virulent ST7 responsible 
for two human outbreaks in China and the intermediate 
and low virulent ST25 and ST28, respectively, in North 
America [4]. A variety of virulence factors have been pro-
posed to be involved in the S. suis pathogenesis, includ-
ing capsular polysaccharide, lipoproteins (LPs) and 
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lipoteichoic acid (LTA) modifications [5]. Moreover, ST1 
and ST7 strains produce suilsyin (SLY), a hemolysin simi-
lar to the pneumolysin of Streptococcus pneumoniae and 
which participates in bacterial dissemination and host 
inflammation [6, 7].
A rapid and effective innate immune response against 
S. suis is critical to control bacterial growth and limit the 
spread of the pathogen [8]. Recognition by specialized 
membrane-associated or cytoplasmic receptors (pattern 
recognition receptors [PRRs]) mediates host immune 
responses by inducing mediator production via activa-
tion of nuclear factor-kappa B (NF-ĸB) and mitogen-
activated protein kinases (MAPKs) [9]. Previous studies 
have shown that S. suis activates dendritic cells (DCs) 
and macrophages (MФ) through the myeloid differentia-
tion primary response 88 (MyD88)-dependent Toll-like 
receptor (TLR) pathway [10–12]. Indeed, recognition of 
S. suis occurs via surface-associated TLR2 and, possibly, 
TLR4 [13], while its internalization activates the endoso-
mal TLR7 and TLR9 [14].
Of the different mediators induced during inflamma-
tion, interleukin (IL)-1 is one of the most potent and 
earliest produced, of which there exist two forms (IL-
1α and IL-1β) encoded by separate genes and synthe-
sized as precursor peptides (pro-IL-1α and pro-IL-1β) 
[15]. While pro-IL-1α is biologically active, a two steps 
mechanism is required for the complete maturation of 
IL-1β [16, 17]. Firstly, activation of PRRs leads to tran-
scription and translation of pro-IL-1β, which is then 
cleaved and activated by caspase-1-dependent mecha-
nisms [18]. Moreover, caspase-1 itself requires pro-
teolytic processing mediated by intracellular complexes 
called inflammasomes. Though several inflammasomes 
have been described, the nucleotide-binding oligomeri-
zation domain (NOD)-like receptor (NLR) family pyrin 
domain-containing 3 (NLRP3), the NLRP1, the NLR fam-
ily CARD domain-containing protein 4 (NLRC4), and the 
absent in melanoma 2 (AIM2) are the best characterized 
[19, 20]. Once secreted, IL-1α and IL-1β bind to their 
shared receptor, IL-1 receptor (IL-1R), which is ubiqui-
tously expressed, resulting in the recruitment of inflam-
matory cells and their activation [17].
Although IL-1 signaling plays an essential role in in 
the initiation of the inflammatory response, an uncon-
trolled production of IL-1 can lead to tissue damage and 
disease. While, IL-1 plays a protective role during both 
pneumococcal and Group B Streptococcus (GBS) infec-
tions [21–24], its role is detrimental in a mouse model of 
Group A Streptococcus (GAS) infection [25, 26]. During 
S. suis infection, the host response depends on the abil-
ity of innate immune mechanisms to control initial bacte-
rial growth and limit its spread without causing excessive 
inflammation. However, regardless of the numerous 
studies on the S.  suis pathogenesis, none have focused 
on the production and role of IL-1. Consequently, we 
assessed herein its implication during S. suis serotype 
2 pathogenesis using a classical virulent European ST1 
strain and the highly virulent ST7 strain by evaluating the 
mechanisms involved in its production in  vitro and its 
role in vivo during the systemic infection.
Materials and methods
Bacterial strains, plasmids and growth conditions
The strains and plasmids used in this study are listed in 
Table  1. The classical virulent European reference ST1 
P1/7 strain and the highly virulent Chinese ST7 SC84 
strain were used throughout this study, including for con-
struction of isogenic sly-deficient mutants. S. suis strains 
were grown in Todd Hewitt broth (THB; Becton–Dick-
inson, Mississauga, ON, Canada) [27], diluted in culture 
medium before experiments with cells, and the final con-
centration (colony-forming units [CFU]/mL) determined 
by plating on THB agar (THA). For experimental mouse 
infections, bacteria were resuspended in THB. Escheri-
chia coli was grown in Luria–Bertani (LB) broth or agar 
(Becton–Dickinson). When needed, antibiotics (Sigma-
Aldrich, Oakville, ON, Canada) were added to culture 
media at the following concentrations: for E. coli, ampi-
cillin at 100  mg/mL, kanamycin and spectinomycin at 
50 μg/mL; for S. suis, spectinomycin at 100 μg/mL.
Construction of the isogenic sly‑deficient mutants
Precise in-frame deletion of the sly gene from S. suis 
strains P1/7 and SC84 was achieved using splicing-by-
overlap-extension polymerase chain reaction (PCR) [28]. 
Oligonucleotide primers (Additional file 1) were obtained 
from Integrated DNA Technologies (Coralville, IA, USA) 
and PCRs were carried out with the iProof proofread-
ing DNA polymerase (BioRad Laboratories, Mississauga, 
ON, Canada) or with the Taq DNA polymerase (Qiagen, 
Valencia, CA, USA). Overlapping PCR-products were 
cloned into the plasmid pCR2.1 (Invitrogen, Burlington, 
ON, Canada), extracted using EcoRI, and cloned into the 
thermosensitive E. coli–S. suis shuttle vector pSET4s [29]. 
Final constructions of pSET4s vectors were electroporated 
into competent S. suis as previously described [29]. Dele-
tion of the sly gene was confirmed by PCR and sequencing.
Cloning, expression and purification of recombinant 
suilysin (rSLY)
The sly gene from S. suis strain P1/7, excluding the sig-
nal peptide, was amplified by PCR, after which amplicons 
were digested with NdeI and BamHI and cloned into the 
pIVEX2.4d vector (Roche, Mississauga, ON, Canada), 
which possesses an N-terminal His-tag. Primers used are 
listed in Additional file 1. Protein synthesis was induced 
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in the E. coli BL21 (DE3) strain using 0.5 mM isopropyl-
β-d-thiogalactopyranoside for 4 h, after which cells were 
sonicated. The resulting recombinant His-tag suilysin 
(rSLY) was purified by affinity chromatography using the 
HisPur Ni-NTA Spin Column Kit (Thermo Scientific, 
Rochelle, IL, USA) according to manufacturer’s instruc-
tions. rSLY kept its hemolytic activity as determined 
using red blood cells (see below). Protein quantification 
was measured using the Pierce Bicinchoninic Acid Pro-
tein Assay Kit (Thermo Scientific).
Titration of hemolytic activity
Hemolytic titration was performed by preparing twofold 
serial dilutions of bacterial culture supernatant in a solu-
tion of 0.145 M NaCl and 7 mM  Na2HPO4, pH 7.2, using 
horse red blood cells as previously described [30]. The 
titer was defined as the reciprocal of the highest dilution 
with observed hemolysis.
Lipoteichoic acid preparation
Extraction and purification of LTA from strains P1/7, 
P1/7Δlgt, SC84, and SC84Δlgt has recently been described 
[31].
Mice
MyD88−/−  [B6.129P2(SJL)-MyD88tm1.Defr/J],  TRIF−/− 
[C57BL/6  J-Ticam1Lps2/J],  TLR2−/− [B6.129-Tlr2tmKir/J], 
 TLR4−/− [B6.B10ScN-Tlr4lps−del/JthJ], caspase-1−/− 
[B6N.129S2-Casp1tm1Flv/J],  NLRP3−/− [B6.129S6-
Nlrp3tm1Bhk/J],  NLRP1−/− [B6.129S6-Nlrp1btm1Bhk/J], 
 AIM2−/− [B6.129P2-Aim2Gt(CSG445)Byg/J],  NLRC4−/− [32], 
and IL-1R−/− [B6.129S7-Il1r1tm1Imx/J] mice on C57BL/6 
background were housed under specific pathogen-free 
conditions alongside their wild-type counterparts. Mice 
were purchased from Jackson Research Laboratories (Bar 
Harbor, ME, USA), except for  NLRC4−/− mice, generated 
by Dr. G. Núñez (University of Michigan, USA) [33].
Generation of bone marrow‑derived dendritic cells 
and macrophages
Hematopoietic stem cells from femurs and tibias of wild-
type and knockout mice were used to generate bone 
marrow-derived DCs (bmDCs) as previously described 
[11, 14] in RPMI-1640 supplemented with 5% heat-inac-
tivated fetal bovine serum, 10 mM HEPES, 2 mM l-glu-
tamine, and 50  µM 2-mercaptoethanol (all from Gibco, 
Burlington, ON, Canada) and complemented with 
10% granulocyte–macrophage colony-stimulating fac-
tor. For macrophages (MΦ), hematopoietic stem cells 
(5 × 105  cells/mL) were cultured in Dulbecco’s Modified 
Eagle’s Medium supplemented with 10% heat-inactivated 
fetal bovine serum (Gibco) and complemented with 30% 
L929 cell-derived macrophage colony-stimulating factor 
supernatant [34]. Cells were cultured for 8 days at 37 °C 
with 5%  CO2 and trypsinized using 0.05% trypsin-0.03% 
EDTA (Gibco) prior to infection. Cell purity was at least 
85%  CD11c+ or F4/80+ for bmDCs and MΦ, respectively. 
Albeit this culture system cannot completely rule out the 
presence of other innate cells (such as macrophages), it 
represents an enriched source of bmDCs.
S. suis infection of bone marrow‑derived dendritic cells 
and macrophages
All activation studies were done with endotoxin-free 
material and under non-toxic conditions as evaluated 
Table 1 Bacterial strains and plasmids used in this study 
Strain/plasmid General characteristics Source/references
Streptococcus suis
 P1/7 Classical virulent serotype 2 ST1 strain isolated from a pig with meningitis in the UK [69]
 P1/7Δsly Isogenic mutant strain derived from P1/7; in frame deletion of sly gene This work
 P1/7Δlgt Isogenic mutant strain derived from P1/7; in frame deletion of lgt gene [31]
 SC84 Highly virulent serotype 2 ST7 strain isolated from a human case of streptococcal toxic shock‑like syndrome 
during the 2005 human outbreak in China
[70]
 SC84Δsly Isogenic mutant strain derived from SC84; in frame deletion of sly gene This work
 SC84Δlgt Isogenic mutant strain derived from SC84; in frame deletion of lgt gene [31]
Escherichia coli
 TOP 10 F− mrcA Δ(mrr‑hsdRMS‑mcrBC) φ80 lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara‑leu) 7697 galU galK rpsL  (StrR) 
endA1 nupG
Invitrogen
 BL21 F−ompT hsdSB (rB
−, mB
−) gal dcm rne131 (DE3) Invitrogen
Plasmids
 pIVEX2.4d Apr, pUC ori, T7 promoter, His tag‑coding sequence Roche Bioscience
 pSET4Δsly pSET4 s carrying the construct of sly gene for allelic replacement This work
 pIVEXsly pET101 carrying sly gene for protein production This work
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using the CytoTox  96® Non-Radioactive Cytotoxicity 
Assay (Promega, Madison, WI, USA). Cells were resus-
pended at 1 × 106 cells/mL in complete medium and 
stimulated with the different S. suis serotype 2 strains 
listed in Table  1 (1 × 106 CFU/mL; initial multiplicity 
of infection = 1). Conditions used were based on those 
previously published [6, 11]. At indicated times, super-
natants were collected for cytokine measurement. For 
mRNA expression, cells were harvested in TRIzol (Invit-
rogen) 6 h following infection. Mock-infected cells served 
as negative controls. Activation of cells with LTA was 
performed using 30  μg/mL and supernatants collected 
24  h later for IL-1β quantification. For signaling path-
way studies, cells were pretreated for 30 min with 10 μM 
NF-κB inhibitor JSH-23, 10 μM p38 inhibitor SB0203580, 
25  μM MEK1/2 inhibitor U0126 or 10  μM JNK inhibi-
tor SP600125 (all from Calbiochem/EMD Millipore, San 
Diego, CA, USA), in dimethyl sulfoxide (DMSO; Sigma-
Aldrich), which served as the vehicle. For assays with 
rSLY, a non-toxic concentration of 5  μg/mL was used 
during 16 h. For cholesterol inhibition assays, 40 μg/mL 
of cholesterol (Sigma-Aldrich) was added to wells [30]. 
When needed, 0.25  mg/mL alhydrogel (Brenntag, Mül-
heim, Germany) was added as a NLRP3 activator imme-
diately upon infection of cells. Finally, for experiments 
involving extracellular  K+, a stock solution of KCl (Lab-
oratoire Mat. Inc., Quebec City, QC, Canada) was pre-
pared and appropriately diluted.
S. suis DNA and RNA preparation and transfection of cells
Bacterial DNA and RNA isolation was performed as pre-
viously described [14]. Cells were transfected with 1  μg 
of RNA or DNA complexed or not with DOTAP liposo-
mal transfection reagent (Sigma-Aldrich) as previously 
described [14].
Cytokine and chemokine quantification in cell culture 
supernatants
Levels of IL-1α, IL-1β, IL-6, and tumor necrosis fac-
tor (TNF) in cell culture supernatants were measured 
by sandwich enzyme-linked immunosorbent assay 
(ELISA) using pair-matched antibodies from R&D Sys-
tems (Minneapolis, MN, USA) according to the manu-
facturer’s recommendations.
Determination of cell mRNA expression by RT‑qPCR
Cell mRNA was extracted according to the manufac-
turer’s instructions (TRIzol). RNA purity was assessed 
by spectrophotometric quantification and integrity 
verified by electrophoresis on denaturating agarose 
gel. cDNA was generated using the Quantitect cDNA 
Synthesis Kit (Qiagen, Mississauga, ON, Canada) with 
500 ng of RNA pretreated with DNase. Real-time qPCR 
was performed on the CFX-96 Touch Rapid Ther-
mal Cycler System (Bio-Rad) using 250 nM of primers 
(Integrated DNA technologies), the SsoFast Evagreen 
Supermix Kit (Bio-Rad) and 20  ng of cDNA. No tem-
plate controls were included and all samples were run 
in triplicate. The cycling conditions were 3 min of pol-
ymerase activation at 98  °C, followed by 40 cycles at 
98 °C for 2 s and 57 °C for 5 s. Melting curves were gen-
erated after each run to confirm the presence of a sin-
gle PCR product. The sequences of primers used in this 
study are shown in Additional file  1 and were verified 
to have reaction efficiencies between 90 and 110%. The 
reference genes Atp5b and Gapdh, determined to be 
the most stably expressed using the algorithm geNorm, 
were used to normalize data. Fold changes in gene 
expression were calculated using the quantification 
cycle threshold (Cq) method using the CFX software 
manager v.3.0 (Bio-Rad). Samples from mock-infected 
cells served as calibrators.
S. suis serotype 2 mouse model of infection
Six-week-old male and female wild-type C57BL/6 and 
IL-1R−/− mice were used. Animals were acclimatized to 
standard laboratory conditions with unlimited access to 
water and rodent chow [35]. These studies were carried 
out in strict accordance with the recommendations of 
and approved by the University of Montreal Animal Wel-
fare Committee guidelines and policies, including eutha-
nasia to minimize animal suffering, applied throughout 
this study when animals were seriously affected since 
mortality was not an end-point measurement. The differ-
ent S. suis serotype 2 strains or the vehicle solution (ster-
ile THB) were administered at a dose of 1 × 107 CFU by 
intraperitoneal inoculation. Survival was evaluated and 
mice monitored at least three times daily until 7  days 
post-infection (pi).
Measurement of plasma, liver and spleen 
pro‑inflammatory mediators
For kinetics of IL-1α and IL-1β production, blood from 
infected mice was collected by intracardiac puncture 
following euthanasia and anti-coagulated with EDTA 
(Sigma-Aldrich) as previously described [8, 36]. Plasma 
was collected following centrifugation at 10 000 × g for 
10  min at 4  °C. For liver and spleen, extraction buffer 
was prepared using complete Mini, EDTA-free, protease 
inhibitor cocktail tablets (Roche Diagnostics GmbH, 
Mannheim, Germany) according to the manufacturer’s 
instructions and organs homogenized using a POL-
YTRON PT 1200E system bundle (Kinematica, Lucerne, 
Switzerland). Homogenate supernatants were collected 
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following centrifugation at 10  000  ×  g  for 10  min at 
4  °C. Levels of IL-1α and IL-1β were determined by 
ELISA, while IL-6, IL-12p70, interferon (IFN)-γ, C–C 
motif chemokine ligand (CCL) 2, CCL3, and C–X–C 
motif chemokine ligand (CXCL) 9 were measured using 
a custom-made cytokine Bio-Plex Pro™ assay (Bio-Rad). 
Acquisition was performed on the MAGPIX platform 
 (Luminex®) and data analyzed using the Bio-Plex Man-
ager 6.1 software (Bio-Rad).
Measurement of blood, spleen and liver bacterial burden
Wild-type and IL-1R−/− mice were inoculated with S. 
suis as described above and blood bacterial burden was 
assessed 12  h and 48  h pi by collecting blood from the 
caudal vein. For liver and spleen, organs were collected 
and homogenized as described above. Bacterial burden 
was determined by plating appropriate dilutions on THA.
Statistical analyses
Normality of data was verified using the Shapiro–Wilk 
test. Accordingly, parametric (unpaired t-test) or non-
parametric tests (Mann–Whitney rank sum test), where 
appropriate, were performed to evaluate statistical dif-
ferences between groups. Log-rank (Mantel–Cox) tests 
were used to compare survival between wild-type and 
IL-1R−/− mice. Each test was repeated in at least three 
independent experiments. p < 0.05 was considered as sta-
tistically significant.
Results
S. suis serotype 2 induces elevated levels of IL‑1 in organs 
but not in plasma
Systemic levels of both IL-1α and IL-1β were measured in 
plasma, liver and spleen following infection with the clas-
sical European ST1 strain P1/7 and the highly virulent ST7 
strain SC84. IL-1β levels were barely detectable in mock-
infected animals and did not change between 6 to 48  h. 
Similarly, IL-1β levels were scarcely detectable in plasma 
throughout the course of infection, including upon presen-
tation of severe clinical signs of systemic disease, with no 
significant differences between strains (Figures 1A and B). 
By contrast, levels of IL-1β in liver and spleen were very 
high and reached maximum values during the first 12 h pi, 
rapidly decreasing thereafter, with similar production pat-
terns in both organs and between strains (Figures 1C–F). 
Moreover, IL-1α production patterns in plasma, liver and 
spleen were similar to IL-1β (Figure 2). 
S. suis induces IL‑1 release from bone marrow‑derived 
dendritic cells and macrophages in a strain‑dependent 
manner
Given the elevated levels of IL-1 produced in liver 
and spleen and the fact that DCs and MФ are highly 
important during S. suis infection [11, 14], the capacity of 
these cells to produce IL-1 following S. suis infection was 
evaluated. Strain P1/7 induced modest levels of IL-1β in 
a time-dependent manner, with production by bmDCs 
being significantly greater than that by MФ at 12 h and 
16 h (p < 0.001) (Figure 3). On the other hand, the highly 
virulent ST7 strain SC84 induced significantly higher 
levels of IL-1β compared to strain P1/7 (Figure 3) at 8 h, 
12 h and 16 h pi (p < 0.05) in both cell types. In fact, lev-
els induced by strain SC84 16 h pi were approximately 40 
times higher than those induced by strain P1/7. Interest-
ingly, a slight delay in IL-1β production was observed by 
SC84-stimulated MФ in comparison to bmDCs. Moreo-
ver, IL-1α kinetics by bmDCs and MФ were similar to 
those obtained for IL-1β (Additional file 2). Importantly, 
production was not the result of cell death, since toxicity 
levels remained low (data not shown). Given that IL-1α 
and IL-1β production kinetics were similar and that both 
cell types responded similarly, subsequent experiments 
were only performed for IL-1β using bmDCs following 
16 h of infection.
Role of Toll‑like receptors and associated signaling 
pathways in S. suis‑induced IL‑1β production
To better understand the differential IL-1β production 
induced by strains P1/7 and SC84, the role of different 
receptors and signaling pathways involved in this pro-
duction was evaluated. Production of IL-1β was almost 
completely abrogated in the absence of MyD88 following 
infection with both S. suis strains (p < 0.01) (Figure  4A). 
By contrast, production was independent of the TIR-
domain-containing adapter-inducing IFN-β (TRIF) (Fig-
ure  4A). Since S. suis is an extracellular pathogen, its 
recognition by surface-associated receptors is crucial. 
While IL-1β production was significantly (but not totally) 
reduced in  TLR2−/− bmDCs stimulated with P1/7 or 
SC84 (p < 0.01), no difference was observed with  TLR4−/− 
bmDCs (Figure 4A).
Subsequently, potential activators of TLR2 were inves-
tigated: though still controversial, the LTA and LPs of 
Gram-positive bacteria have been suggested to be activa-
tors of TLR2 [37, 38]. Consequently, LTA was extracted 
from both strains and used to activate bmDCs, with LTA 
from strains P1/7 and SC84 inducing similarly high levels 
of IL-1β (Figure 4B). However, current methods are una-
ble to eliminate co-purified LPs from LTA preparations 
[39]. As such, LTA was also extracted from lgt-deficient 
mutants (Δlgt), in which absence of the lipoprotein dia-
cylglyceryl transferase, a key enzyme in LP synthesis, 
renders LPs unrecognizable by TLR2 [40]. In accordance, 
not only did LTA preparations from lgt-deficient mutants 
induce significantly less IL-1β than those from wild-type 
strains (p < 0.01), but levels were in fact undetectable 
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(Figure 4B). In addition, IL-1β production was completely 
abolished in  TLR2−/− bmDCs following activation with 
LTA preparations from wild-type strains (p < 0.01) (Fig-
ure  4B), indicating that co-purified LPs, but not S.  suis 
LTA, are important inducers of IL-1β by bmDCs via rec-
ognition by TLR2.
Though an  extracellular  bacterium, dependence of 
S. suis-induced IL-1β production on MyD88, but only 
partially on TLR2 (and not at all on TLR4), suggested a 
potential role of endosomal TLRs. To evaluate this, DNA 
and RNA were extracted from strains P1/7 and SC84 
and complexed or not with DOTAP liposomal trans-
fection reagent, which allows phagosomal delivery. In 
the absence of DOTAP S.  suis DNA and RNA did not 
induce IL-1β production from bmDCs (data not shown). 
Meanwhile, DNA and RNA from both strains induced 
Figure 1 S. suis induces elevated levels of IL‑1β in liver and spleen but not in plasma. C57BL/6 mice were intraperitoneally inoculated with 
the S. suis strain P1/7 (white bars) or SC84 (gray bars). Plasma (A, B), spleen (C, D) and liver (E, F) were collected at different times post‑infection and 
levels of IL‑1β were quantified by ELISA. Values for mock‑infected controls did not change between 6 and 48 h. As such, 0 h represents results for 
mock‑infected mice throughout the experiment. Data are expressed as mean ± SEM (n = 3).
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significant, but similar production when complexed with 
DOTAP (p < 0.05) (Figure  4C). At the same concentra-
tion, S. suis DNA induced greater IL-1β production than 
RNA (p < 0.01). When Alum was added, a known activa-
tor of the NLRP3 inflammasome, a significantly higher 
production was observed for both genetic materials 
(Additional file 3) (p < 0.05). Consequently, recognition of 
RNA and DNA may suggest an involvement of TLR7 and 
TLR9, respectively, in S. suis-induced IL-1β production.
TLR activation triggers various intracellular signal-
ing pathways of which the NF-kB pathway and MAPK 
p38, Jun N-terminal kinase (JNK) and extracellular-
regulated kinase (ERK) are the most important [41]. To 
determine the role of these pathways in S. suis-induced 
Figure 2 S. suis serotype 2 induces elevated levels of IL‑1α in liver and spleen, but not in plasma. C57BL/6 mice were intraperitoneally 
inoculated with S. suis strain P1/7 (white bars) or SC84 (gray bars). Plasma (A, B), spleen (C, D), liver (E, F) were collected at different times 
post‑infection and levels of IL‑1α were quantified by ELISA. Values for mock‑infected controls did not change between 6 and 48 h. As such, 0 h 
represents results for mock‑infected mice throughout the experiment. Data are expressed as mean ± SEM (n = 3).
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Figure 3 IL‑1β released from bone marrow‑derived dendritic cells (bmDCs) and macrophages (MФ) stimulated with S. suis is 
strain‑dependent. IL‑1β kinetics as measured by ELISA following infection of bmDCs (A) or MФ (B) with strain P1/7 (white bars) or SC84 (gray bars). 
Non‑stimulated cells served as negative control (C‑). Data are expressed as mean ± SEM (n = 4).
Figure 4 Role of Toll‑like receptors (TLRs) and associated signaling in S. suis‑induced IL‑1β production by bone marrow‑derived dendritic 
cells (bmDCs). A Percentage of IL‑1β production induced by S. suis strain P1/7 (white bars) or SC84 (gray bars) 16 h following infection of bmDCs 
deficient for MyD88, TRIF, TLR2 or TLR4, with regards to wild‑type counterparts (normalized to 100%); B IL‑1β production 24 h following activation of 
wild‑type (WT) or  TLR2−/− bmDCs with 30 μg/mL of LTA extracts from strains P1/7 or SC84 or their lgt‑deficient mutants (Δlgt); C IL‑1β production 
by bmDCs following phagosomal delivery of 1 µg of S. suis RNA or DNA; D Percentage of IL‑1β production from bmDCs following pre‑treatment 
with inhibitors of either NF‑kB, p38, MEK or JNK and infection with S. suis, with regards to vehicle‑treated bmDCs (DMSO; normalized to 100%). Data 
are expressed as mean ± SEM (n = 3). #p < 0.05) indicates a significant difference with wild‑type bmDCs (normalized to 100%); $(p < 0.05) indicates a 
significant difference with negative control (elution buffer); *(p < 0.05) indicates a significant difference with vehicle‑treated bmDCs (normalized to 
100%).
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IL-1β production, bmDCs were pre-treated with inhibi-
tors (NF-κB inhibitor JSH-23, p38 inhibitor SB203580, 
MEK1/2 inhibitor U0126 or JNK inhibitor SP600125) or 
the vehicle (DMSO). Treatment with NF-κB inhibitor 
reduced secretion of IL-1β induced by both strains by 
approximately 50% (p < 0.01) (Figure  4D). Interestingly, 
different IL-1 production by strains P1/7 and SC84 was 
observed upon p38 inhibition: while p38 inhibitor had no 
effect on P1/7-induced IL-1β production, it significantly 
reduced SC84-induced IL-1β (p < 0.01) (Figure  4D). 
Finally, treatment with MEK1/2 inhibitor reduced IL-1β 
production by 90% for both strains (p < 0.01) while JNK 
inhibitor had no effect (Figure 4D). Consequently, except 
for p38 activation, S. suis strains P1/7 and SC84 use simi-
lar receptors and signaling pathways in the induction of 
IL-1β.
S. suis induces inflammasome activation required for IL‑1β 
maturation in a strain‑dependent manner
To investigate whether maturation of S. suis-induced 
IL-1β requires caspase-1, bmDCs deficient for this 
enzyme was used. IL-1β production was reduced by more 
than 75% in caspase-1−/− bmDCs (p < 0.01), indicating 
that it is essential for maturation of IL-1β following infec-
tion by both strains (Figure  5A). Subsequently, the role 
of different inflammasomes was investigated. Though 
several inflammasomes have been described, NLRP1, 
NLRP3, AIM2, and NLRC4 are the best characterized 
[19]. While NLRP3- or AIM2-deficiency resulted in a 
partial decrease of IL-1β release following stimulation 
with P1/7 (p < 0.05), there was no significant involvement 
of NLRP1 or NLRC4 (Figure  5A). Unexpectedly, IL-1β 
maturation induced by strain SC84 involved all four 
inflammasomes tested (p < 0.05), with a major implication 
of NLRP3 (Figure 5A). Specific activation was confirmed 
by measuring TNF, which is inflammasome-independent 
(Additional file 4).
Since inflammasome activation was different between 
the strains, we hypothesized that differential maturation, 
but not induction, of IL-1β could be responsible for the 
different levels induced in vitro. To confirm this hypothe-
sis, IL-1β mRNA levels induced by both strains were eval-
uated. In accordance, levels of IL-1β expression induced 
by strains P1/7 and SC84 were similar (Figure 5B).
Figure 5 Implication of caspase‑1 and inflammasomes in S. suis‑induced IL‑1β bone marrow‑derived dendritic cell (bmDC) production is 
strain‑dependent. A Percentage of IL‑1β secretion by caspase‑1 (CASP‑1), NLRP3, AIM2, NLRP1 or NLRC4‑deficient bmDCs induced by P1/7 (white 
bars) or SC84 (gray bars) after 16 h of incubation, in comparison to wild‑type counterparts (normalized to 100%); B bmDCs were infected with P1/7 
and SC84 strains for 6 h and IL‑1β mRNA expression was measured by RT‑qPCR. Data are presented as “fold” increase in mRNA expression relative to 
non‑infected cells. C bmDCs were infected with either strain P1/7 or SC84 in the presence of different concentrations of KCl and IL‑1β production 
was measured after 16 h by ELISA. Data are expressed as mean ± SEM (n = 4). *(p < 0.05) indicates a significantly difference with wild‑type or 
non‑treated bmDCs and #(p < 0.05) indicates a difference between P1/7 and SC84.
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S. suis‑induced IL‑1β production is blocked by additional 
extracellular potassium
Potassium  (K+) efflux is a common denominator in the 
assembly and activation of inflammasomes [19, 42]. Con-
sequently, production of IL-1β by S. suis-infected bmDCs 
exposed to increasing concentrations of extracellular  K+, 
used to inhibit its efflux, was evaluated. Ten mM of extra-
cellular  K+ was sufficient to significantly inhibit IL-1β 
induced by both strains (p < 0.05) (Figure 5C). However, 
the effect was significantly greater for strain SC84 than 
for strain P1/7 (p < 0.01) (Figure  5C). Moreover, inhibi-
tion was dose-dependent, and this regardless of strain. 
Importantly though, at concentrations equal to or greater 
than 40 mM, the decreased levels of IL-1β observed were 
non-specific due to cell death (data not shown). Non-spe-
cific inhibition of IL-1β production by  K+ efflux at con-
centrations between 10  mM and 30 mM was discarded 
by measuring TNF and IL-6 production, which were not 
inhibited (Additional file 5).
Elevated suilysin production by the ST7 strain is required 
for efficient pro‑IL‑1β maturation by bone marrow‑derived 
dendritic cells
Given that pore-forming toxins have the ability to 
induce  K+ efflux [19] and that S. suis produces SLY, its 
role in IL-1β production was evaluated. ST7 strains were 
reported to have an increased SLY production in com-
parison to other serotype 2 strains [43], which we con-
firmed by measuring the hemolytic activity in P1/7 and 
SC84 supernatants (data not shown). To evaluate if SLY 
is implicated in S. suis-induced IL-1β release, sly-defi-
cient isogenic mutants were constructed. No difference 
in IL-1β production was observed in the absence of SLY 
from strain P1/7 (Figure 6A). By contrast, absence of SLY 
from strain SC84 resulted in a significant decrease of 
secreted IL-1β (p < 0.001), suggesting that the higher lev-
els of SLY produced by this strain are implicated in IL-1β 
production (Figure 6A). Moreover, IL-1β levels produced 
by SC84Δsly were similar to those obtained with both 
wild-type P1/7 and P1/7Δsly, suggesting that conserved 
components are responsible for the basal production of 
IL-1β by both strains (Figure  6A). In addition, the lack 
of differences in IL-1β mRNA expression between the 
wild-type and sly-deficient mutants confirms that SLY 
participates in pro-IL-1β maturation rather than in IL-1β 
induction (Figure 6B).
Since SLY is a cholesterol-dependent cytolysin, choles-
terol inhibits its effects [30]. Consequently, cholesterol 
was added to bmDCs infected with the different S.  suis 
wild-type and sly-deficient strains and did not itself 
induce IL-1β production (Figure  6C). While addition of 
cholesterol had no effect on IL-1β production by strains 
P1/7, P1/7Δsly or SC84Δsly, it significantly decreased 
production induced by the wild-type strain SC84 
(p < 0.001), with residual levels being similar to those 
measured for P1/7, P1/7Δsly and SC84Δsly (Figure 6C).
Meanwhile, activation with rSLY alone induced moder-
ate levels of IL-1β from bmDCs (Figure  6D). Since SLY 
has been suggested to induce TNF production following 
recognition by TLR4 [13],  TLR4−/− bmDCs were acti-
vated with rSLY. However, IL-1β production was TLR4-
independent (Additional file  6). Meanwhile, addition of 
a non-toxic concentration of 5  μg/mL of rSLY resulted 
in a synergistic, but similar increase of IL-1β production 
by strains P1/7, P1/7Δsly and SC84Δsly (p < 0.01), which 
was abolished following treatment with cholesterol 
(Figure 6D).
Strain‑dependent role of IL‑1 signaling in host survival 
during S. suis systemic infection
Given the capacity of S. suis to induce IL-1 in vitro and 
in vivo, its implication in systemic inflammation and host 
survival was evaluated. Survival of IL-1R−/− mice was 
significantly decreased in comparison to wild-type coun-
terparts following infection with strain P1/7 (p < 0.01) 
(Figure 7A). Following infection with strain SC84, how-
ever, no statistical difference was observed between sur-
vival of wild-type and IL-1R−/− mice (Figure 7B).
To better understand this difference, and since IL-1 is 
involved in initiation and amplification of inflammation, 
production of pro-inflammatory mediators in plasma, 
spleen and liver was evaluated 12  h pi. While IL-1α 
and IL-1β levels in WT and IL-1R−/− mice were similar 
(Additional file 7), levels of IL-6, IL-12p70, IFN–γ, CCL2, 
CCL3, and CXCL9 were significantly lower in IL-1R−/− 
mice compared with wild-type mice following infection 
with P1/7 (p < 0.05) (Figure  8). Following infection with 
strain SC84 however, levels of mediators were simi-
larly exacerbated in both wild-type and IL-1R–−/− mice 
(Figure 8).
Though inflammation is required for clearance of bac-
teria during S. suis systemic infection, it can also lead to 
host death if uncontrolled. Consequently, bacterial load 
in blood, spleen and liver was evaluated 12  h and 48  h 
following infection with strains P1/7 and SC84. No dif-
ferences were observed between wild-type and IL-1R−/− 
mice 12 h pi regardless of strain (Figure 9). Interestingly, 
48  h p.i. following infection with P1/7 strain, bacte-
rial burden was significantly higher in plasma, liver and 
spleen of IL-1R−/− mice (p < 0.01) (Figure 9). By contrast, 
no differences were observed following infection with 
strain SC84, and this for all organs (Figure  9). Notably, 
bacterial load of wild-type mice infected with strain P1/7 
or SC84 were similar at 12 h and 48 h pi.
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Figure 6 Suilysin (SLY) is involved in the maturation of S. suis‑induced IL‑1β by bone marrow‑derived dendritic cells (bmDCs). A bmDCs 
were infected with the S. suis wild‑type strains P1/7 and SC84 or their SLY‑deficient mutants (∆sly) for 16 h and IL‑1β release was measured by 
ELISA; B bmDCs were infected with the different wild‑type and mutant strains for 6 h and IL‑1β mRNA expression was measured by RT‑qPCR. Data 
are presented as “fold” increase in mRNA expression relative to non‑infected cells. C bmDCs were stimulated with the different strains of S. suis in 
the presence or absence of cholesterol (CHOL) for 16 h and IL‑1β production was measured by ELISA; D bmDCs were infected with the different 
strains of S. suis alone, in combination with 5 μg/mL of rSLY or with 5 μg/mL of rSLY and CHOL. Data are expressed as mean ± SEM (n = 3). #(p < 0.05) 
indicates a significant difference between SC84 and SC84Δsly and *(p < 0.05) with bacteria alone.
Figure 7 Survival of wild‑type (WT) and IL‑1 receptor‑deficient (IL‑1R−/−) mice following S. suis systemic infection. WT and IL‑1R−/− mice 
were inoculated with strain P1/7 (A) or SC84 (B) and survival was monitored. Data represent survival curves (n = 15). *(p < 0.05) indicates a significant 
difference between survival of WT and IL‑1R−/− mice.
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Discussion
Previous studies showed low levels of IL-1 in plasma 
after experimental infection with S. suis, in compari-
son with other important pro-inflammatory cytokines 
such as TNF or IL-6 [8, 35]. As such, the low levels of 
IL-1 observed herein in plasma after infection with both 
strains were not surprising and not related to the strain 
virulence level. Several factors could explain this near 
lack of IL-1, including its short half-life in plasma [44] 
and its association with other plasmatic proteins [45]. To 
our knowledge, however, there has been no other study 
evaluating plasma levels of IL-1 during infection by other 
streptococci using similar models systemic of infection. 
On the other hand, high levels of IL-1α and IL-1β were 
found in liver and spleen, which are two important filter 
organs. Previous studies with GBS also reported elevated 
levels of IL-1β in kidneys [23]. Therefore, although IL-1 
cannot be found in plasma, activation of immune cells by 
infiltrating bacteria in liver and spleen might be responsi-
ble for the induction of IL-1, which remains locally.
Figure 8 Pro‑inflammatory mediator production in plasma, spleen and liver during S. suis systemic infection. Plasma, spleen and liver 
levels of IL‑6 (A), IL‑12p70 (B), IFN‑γ (C), CCL2 (D), CCL3 (E), and CXCL9 (F) in wild‑type (WT) and IL‑1R−/− mice 12 h following infection with strain 
P1/7 or SC84 strain. Data are expressed as mean ± SEM (n = 3). *(p < 0.05) indicates a significant difference between WT and IL‑1R−/− mice.
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To further analyze differences in IL-1 signaling 
between strains, in  vitro studies with bmDCs and MΦs 
were performed. Interestingly, production by MΦ was 
somewhat delayed compared to that by bmDCs follow-
ing infection with both strains. This seems to be a char-
acteristic of streptococci, as it was also reported for GBS, 
GAS and S.  pneumoniae [46–48], and might be due to 
a less efficient capacity of macrophages to process pro-
IL-1β into its mature form. The high production of IL-1 
in vivo, but only partial contribution of bmDCs and MΦ, 
suggests the implication of other immune cell types, of 
which neutrophils were also demonstrated to be a source 
during GBS infection [49].
Figure 9 IL‑1 signaling is required for control of bacterial burden in blood, liver and spleen only for S. suis P1/7 strain. Bacterial burden 
in blood (A, B), liver (C, D) and spleen (E, F) of wild‑type (WT) and IL‑1R−/− mice infected with strain P1/7 or SC84 12 h (left panels) or 48 h (right 
panels) post‑infection. A blood bacterial burden of 2 × 109 CFU/mL, corresponding to the average burden upon euthanasia, was attributed to 
euthanized mice. Data represent the geometric mean (n = 6). *(p < 0.05) indicates a significant difference between WT and IL‑1R−/− mice.
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Unlike with most other cytokines, IL-1β production is 
controlled by a two-step signaling process. Firstly, activa-
tion of PRRs such as TLRs leads to the transcription of 
pro-IL-1β. Subsequently, a second signal induces cleav-
age of the precursor into active IL-1β through capsase-1- 
and inflammasome-dependent maturation. The higher 
levels of IL-1β induced by strain SC84, in comparison to 
strain P1/7, suggested differential cell activation or pro-
cessing mechanisms. However, the cellular activation 
leading to IL-1β production was similar for both strains, 
indicating that the recognized components are relatively 
well-conserved. In addition, production of IL-1β was 
MyD88-dependent and partially involved recognition of 
surface lipoproteins by TLR2. Comparable results were 
reported for GBS and S.  pneumoniae, suggesting that 
recognized bacterial motifs might even be conserved 
amongst streptococci [46, 50]. Meanwhile, early studies 
suggested that certain toxins such as pneumolysin [51], 
listeriolysin O [52] and, more recently, SLY [13], may acti-
vate cells trough TLR4, an extracellular receptor which 
can signal via MyD88. However, the capacity of these 
toxins to activate TLR4 remains controversial. More 
recent studies with S. pneumoniae (including recombi-
nant pneumolysin) showed that production of IL-1 was 
TLR4-independent [48, 53]. Indeed, we demonstrated 
that IL-1β production by bmDCs induced by SLY-pos-
itive P1/7 and SC84 strains as well as rSLY was TLR4-
independent [11, 12]. Moreover, IL-1β production was 
TRIF-independent, confirming the lack of TLR4 impli-
cation, since this adaptor protein is engaged by the latter 
and TLR3. To our knowledge, this is the first study eval-
uating the role of TRIF during S. suis infection. Finally, 
although considered a classical extracellular pathogen, 
S.  suis strains P1/7 and SC84 can be internalized, albeit 
at low rates, and the nucleic acids can be recognized by 
TLR7 and TLR9 [14]. In this study, we demonstrated 
that RNA and DNA have the capacity to induce IL-1β, 
and equally so for both strains. Importantly, production 
was only observed when DNA and RNA were complexed 
with DOTAP, suggesting that recognition occurs in a 
process similar to that of IFN-β, following internalization 
and degradation [14].
Following engagement of TLRs, activation of the 
MAPK and NF-κB signaling pathways results in the ini-
tiation of an inflammatory response leading to cytokine 
production. IL-1β production by bmDCs induced by both 
strains was dependent on the NF-κB and ERK pathways, 
but independent of JNK, similar to what has previously 
described for other cytokines induced by S.  suis [54] 
and for other streptococci [55–57]. Meanwhile, IL-1β 
production induced by strain SC84, but not by strain 
P1/7, was also p38-dependent, suggesting differential 
mechanisms, possibly due to differences in bacterial 
components or virulence. Indeed, pore-forming toxin 
secretion and its induced osmotic stress were observed to 
modulate MAPK phosphorylation for listeriolysin O and 
streptolysin O [55, 58]. As such, the higher production of 
SLY by strain SC84 could be involved in p38 activation, 
which remains to be confirmed.
Receptors and pathways engaged by this pathogen 
could not explain the differences observed in IL-1β pro-
duction between strains. Moreover, IL-1β gene induction 
confirmed that the first step involved in this produc-
tion is similar. Consequently, the steps involved in its 
maturation were evaluated. Though IL-1β production 
induced by both strains depended on caspase-1, inflam-
masome activation was different between strains: while 
maturation of pro-IL-1β induced by strain P1/7 was only 
partially dependent on NLRP3 and AIM2, strain SC84 
activated NLRP3 and, to a lesser extent AIM2, NLRP1 
and, surprisingly, NLRC4. These differences in inflam-
masome activation between strains, both in the different 
inflammasomes activated and their implication levels, 
could explain the differential IL-1β levels produced by 
bmDCs. Although NLRP3 and AIM2 participate in IL-1β 
release by bmDCs and MΦ following infection by GBS 
and S.  pneumoniae [46, 53], the implication of NLRP1 
and NLRC4 have not yet been described following strep-
tococcal infection [59]. The specific factors responsible 
for S. suis-dependent inflammasome activation are dif-
ficult to determine since all four inflammasomes can be 
activated by a wide range of molecules. Previous stud-
ies showed that NLRP1 could directly sense the pro-
tease activity of the Bacillus  anthracis lethal toxin [60]. 
Although activation of NLRP1 by streptococcal pore-
forming toxins has not yet been evaluated, elevated 
levels of the S. suis SLY might be involved in a similar 
process. Moreover, strain SC84, unlike strain P1/7, also 
possesses a type IV secretion system encoded by its 89 K 
pathogenicity island [61], which might be responsible 
for NLRC4 activation [62]. Regarding the AIM2 inflam-
masome, it has been previously shown to be activated 
by DNA [63]. In accordance, we observed that levels of 
IL-1β induced by DNA were higher than those induced 
by RNA when complexed with DOTAP. Future studies 
using porcine antigen presenting cells, namely DCs and 
MΦ, will be required to confirm that the mechanisms 
implicated in IL-1β induction and maturation are con-
served between the two species, including the receptors 
and inflammasomes involved.
Previous studies showed that bacterial pore-forming 
toxins could play a role in inflammasome activation 
[42]. Herein, we showed that high levels of SLY produc-
tion produced by strain SC84 play an important role and 
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could explain the observed differences between strains. It 
has also been shown that SLY expression by ST7 strains 
(such as the SC84) is 6.3-fold greater at the mRNA level 
and 4.5-fold greater at the protein level than traditional 
ST1 strains, such as P1/7 [42]. However, no differences in 
the SLY produced by both type of strains are expected, 
since it was previously demonstrated that the sly gene is 
highly conserved between S. suis strains with a maximum 
diversity of 1.8% at the nucleotide level [64, 65], This fur-
ther suggests that a minimal level of SLY (threshold) is 
required. In addition, the role observed for SLY is only 
associated with IL-1β maturation since levels of IL-1β 
mRNA where similar between strains. In other words, 
although cell activation by strains P1/7 and SC84 leads 
to similar levels of pro-IL-1β, the high levels of SLY pro-
duced by strain SC84 result in a more efficient matura-
tion of this cytokine. Interestingly, though rSLY itself 
induced some IL-1β secretion from bmDCs, levels were 
similar to those observed when cells were stimulated 
with Alum alone. It has been previously suggested that 
Alum does not induce IL-1 synthesis but causes matura-
tion and release of the IL-1β naturally synthetized by the 
cell [66]. The same principle could apply to rSLY.
Generation of a  K+ efflux could be responsible for the 
mechanism by which SLY stimulates inflammasome 
activation, as previously described for pneumolysin and 
the β-hemolysin of GBS [23, 51]. Indeed, ion fluxes have 
been described to be involved in the assembly of the four 
inflammasomes evaluated, a fact that could explain SC84 
pan-inflammasome activation [19, 42]. In our study, the 
addition of extracellular  K+ inhibited S. suis-induced 
IL-1β production. Importantly, although only 10 mM of 
 K+ was sufficient to reduce IL-1β production, the effect 
was greater for strain SC84. For strain P1/7, the  K+ efflux 
generated could be due to other yet unknown bacterial 
mechanisms that are probably shared by other classical S. 
suis strains and responsible for “normal” inflammasome 
activation by this pathogen.
Following secretion, IL-1α and IL-1β bind their shared 
receptor, IL-1R, leading to cell activation, stimulation and 
secretion of diverse pro-inflammatory cytokines (posi-
tive feedback loop), recruitment of neutrophils and mac-
rophages, and activation of killing mechanisms, amongst 
other effects [67]. Previous studies with GBS and S. pneu-
moniae showed a protective role of IL-1 during infection, 
with its absence altering bacterial clearance and survival 
[21–24]. In the case of S. suis, IL-1 signaling also plays 
a central and beneficial role following infection with 
the ST1 strain P1/7, which represents classical strains. 
Indeed, IL-1 signaling induced by this strain modulates 
the host innate immune response by increasing produc-
tion of other pro-inflammatory mediators required for 
control of bacterial burden in blood and organs, which 
if unrestricted, causes host death. However, and similar 
to what has been described for type I IFN, the “protec-
tive effect” of IL-1 was not observed following infection 
with the highly virulent ST7 strain SC84 [14]. In fact, the 
levels of IL-1 induced by this strain were unable to modu-
late overall inflammation and host outcome since levels 
of inflammatory mediators were exacerbated despite 
similar bacterial loads than those in P1/7-infected mice. 
These results suggest that during S. suis systemic infec-
tion, the levels of induced inflammation play a critical 
role. In accordance, IL-1 signaling itself cannot counter-
balance the exacerbated inflammation induced by SC84 
strain, resulting in host death. Interestingly, this strain 
possesses additional virulence factors such as the 89  K 
pathogenicity island, which is responsible for a greater 
innate immune system activation, resulting in a cytokine 
storm [68]. It should be noted, however, that even in the 
presence of IL-1, mice still succumb to S. suis infection, 
though to a significantly lower degree and rate, demon-
strating the need for a balanced and controlled inflam-
mation. S. suis-induced IL-1 did not autoregulate itself, 
suggesting that levels induced in the first hours of infec-
tion are sufficient to activate the immune system. This 
is in accordance with results obtained during systemic 
infection with GBS, during which levels of IL-1β are simi-
lar between wild-type and IL-1R−/− mice in kidneys, per-
itoneal lavage and brain [23].
In conclusion, this study demonstrates that a classical 
(P1/7) and highly virulent (SC84) S. suis strain induce 
IL-1 in  vivo, but only in internal organs. While both 
strains similarly activate innate immune cells due to con-
served bacterial components such as LPs, high levels of 
the pore-forming toxin SLY play an important role in 
IL-1β maturation via activation of the NLRP1, NLRP3, 
AIM2, and NLRC4 inflammasomes. Based on these 
results, a model of the mechanisms involved in S.  suis-
induced IL-1β production by bmDCs is proposed (Fig-
ure  10). Globally, S. suis-induced IL-1 plays a beneficial 
role during systemic infection by initiating the inflam-
matory cascade. Beyond a certain threshold, however, S. 
suis-induced inflammation cannot be counterbalanced 
by this signaling, making it difficult to discriminate its 
role. Moreover, a better understanding of the underlying 
mechanisms involved in inflammation and subsequent 
bacterial burden will be necessarily to help develop con-
trol measures for this important porcine and zoonotic 
agent. Amongst these, future in vitro studies using por-
cine cells and in vivo studies in pigs will be necessary to 
confirm the results obtained herein using mice.
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Additional files
Additional file 1. Oligonucleotide primers used in this study. 
Additional file 2. IL‑1α release from bone marrow‑derived dendritic 
cells (bmDCs) and macrophages (MФ) stimulated with S. suis is 
strain‑dependent. IL‑1α kinetics as measured by ELISA following infec‑
tion of bmDCs (A and C) or MФ (B and D) with strain P1/7 (white bars) or 
SC84 (gray bars). Non‑stimulated cells served as negative control (C‑). Data 
are expressed as mean ± SEM (n = 4). 
Additional file 3. Addition of Alum enhances S. suis nucleic acid‑
induced IL‑1β production by bone marrow‑derived dendritic cells 
(bmDCs). IL‑1β production by bmDCs following activation with 1 µg of S. 
suis RNA or DNA from strains P1/7 and SC84 in the presence of Alum. Data 
are expressed as mean ± SEM (n = 3). *(p < 0.05) indicates a significant 
difference with negative control (elution buffer). 
Additional file 4. S. suis‑induced TNF production by bone marrow‑
derived dendritic cells (bmDCs) is inflammasome‑independent. 
Percentage of TNF secretion by caspase‑1 (CASP‑1), NLRP3, AIM2, NLRP1 or 
NLRC4‑deficient bmDCs induced by strain P1/7 (white bars) or SC84 (gray 
bars) after 16 h, in comparison to wild‑type counterparts (normalized to 
100%). Data are expressed as mean ± SEM (n = 3). 
Additional file 5. S. suis‑induced IL‑6 and TNF secretion by bone 
marrow‑derived dendritic cells (bmDCs) is independent of additional 
extracellular potassium (K+) concentrations. bmDCs were infected 
with either strain P1/7 or SC84 in the presence of different concentrations 
of KCl and IL‑6 (A) or TNF (B) production was measured after 16 h by ELISA. 
Data are expressed as mean ± SEM (n = 3). 
Additional file 6. IL‑1β production by recombinant suilysin (rSLY) is 
Toll‑like receptor (TLR) 4‑independent. IL‑1β secretion by wild‑type and 
 TLR4−/− bone marrow‑derived dendritic cells stimulated with rSLY (5 μg/
mL) for 16 h. Data are expressed as mean ± SEM (n = 3). 
Additional file 7. IL‑1 does not modulate its own production follow‑
ing S. suis infection. Spleen and liver levels of IL‑1α (A and B) and IL‑1β (C 
and D) in wild‑type (WT) and IL‑1R−/− mice 12 h following infection with 
strain P1/7 or SC84. Data are expressed as mean ± SEM (n = 5).
Abbreviations
AIM2: absent in melanoma 2; bmDC: bone marrow‑derived DC; CFU: 
colony‑forming unit; CCL: C–C motif chemokine ligand; CXCL: C–X–C motif 
chemokine ligand; DC: dendritic cell; DMSO: dimethyl sulfoxide; ELISA: 
enzyme‑linked immunosorbent assay; ERK: extracellular‑regulated kinase; 
GAS: Group A Streptococcus; GBS: Group B Streptococcus; IFN: interferon; 
IL: interleukin; IL‑1R: interleukin‑1 receptor; JNK: Jun N‑terminal kinase; LB: 
Luria–Bertani; LP: lipoprotein; LTA: lipoteichoic acid; MФ: macrophage; MAPK: 
mitogen‑activated protein kinase; MyD88: myeloid differentiation primary 
response 88; NF‑ĸB: nuclear factor‑kappa B; NLR: NOD‑like receptor; NLRC4: 
NLR family CARD domain‑containing protein 4; NLRP: NLR family pyrin 
domain‑containing; NOD: nucleotide‑binding oligomerization domain; PCR: 
polymerase chain reaction; PRR: pattern recognition receptors; rSLY: recombi‑
nant suilysin; SLY: suilysin; ST: sequence type; THA: THB agar; THB: Todd Hewitt 
broth; TLR: Toll‑like receptor; TNF: tumor necrosis factor; TRIF: TIR‑domain‑
containing adapter‑inducing IFN‑β.
Figure 10 Model of the mechanisms involved in S. suis‑induced IL‑1β production by bone marrow‑derived dendritic cells (bmDCs). 1A: 
Strain‑independent recognition of S. suis by bmDCs requires MyD88‑dependent signaling and partially involves TLR2 activation via recognition 
of surface lipoproteins (LPs); 1B: If internalized, S. suis DNA and RNA can induce the production of IL‑1β, possibly via recognition by endosomal 
receptors TLR7 and TLR9; 1C: Recognition of S. suis leads to activation of the NF‑κB and MEK pathways for both strains, alongside p38 for SC84; 1D: 
Strains P1/7 and SC84 induce comparable transcription of IL‑1β mRNA; 2A: For strain P1/7, low levels of suilysin (SLY) and other not yet identified 
bacterial components lead to partial NLRP3 and AIM2 inflammasome activation; 2B: Caspase‑1 cleavage leads to maturation of moderate levels of 
IL‑1β that are then secreted; 3A and 3B: For strain SC84, secretion of high levels of SLY induces an important  K+ efflux, that results in an activation of 
multiple inflammasomes, including NLRP3, NLRP1, AIM2, and NLRC4; however, other bacterial components could also influence this activation. 3C: 
Increased caspase‑1 cleavage leads to a more efficient maturation of the pro‑IL‑1β, resulting in the secretion of high levels of IL‑1β.
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